‘A vaccine for aging in under ten years’

Agemica founder Ronjon Nag on the moonshot company he believes will develop a vaccine for aging and make a dramatic difference to lifespan and healthspan.
Agemica is on a mission to create a vaccine for aging; its platform uses an AI-driven approach to seek out antiaging therapies that address root cau…Read More

Reservoir Neuroscience set to restore health to the aging brain

Kizoo leads $4 million funding round to develop new therapies for neurodegenerative diseases.
Reservoir Neuroscience has announced the completion of a $4 million financing round to support its development of new therapies for neurodegenerative diseases. San Francisco=-based…Read More

Genflow launches two grant-funded longevity research programs

Longevity biotech collaborates with Revatis and EXO Biologics on new research into sarcopenia and SIRT6 MRNA delivery.
Longevity biotech Genflow Biosciences has teamed up with Revatis and EXO Biologics on two new longevity research programs, fueled by grants from the Government of…Read More

Squirrels in space? Fauna Bio snags NASA grant to study hibernation in orbit

Microgravity laboratory will allow the protective effects of hibernation to be assessed in the International Space Station.
Longevity biotech Fauna Bio announced today that one of its researchers has been awarded a NASA Innovative Advanced Concepts (NIAC) grant to…Read More

Calluna Pharma launches with €75m to target inflammatory and fibrotic diseases

New European biopharma company emerges from Oxitope and Arxx merger with a pipeline of antibodies targeting immunological diseases.
Formed by the merger of biotech companies Oxitope Pharma and Arxx Therapeutics, new European biotech Calluna Pharma has emerged, s…Read More